Advanced Insights Platform
Track usage and measure learning with comprehensive training and assessment monitoring
Company profile
Immersive technology to accelerate human excellence
Company profile
Fundamental XR is a leading provider of immersive technology solutions for medical education and surgical training. The company specializes in creating custom VR, AR, and mixed reality simulations for clinical, manufacturing, and commercial teams in the MedTech sector. Their platform combines haptic-enabled virtual reality with advanced imaging technologies to deliver realistic surgical training experiences across multiple specialties including ophthalmology, robotics, interventional cardiology, and orthopedics. With over 500,000 training hours delivered across 200+ healthcare institutions in 50+ countries, Fundamental XR has demonstrated significant impact with 95% skill retention rates and 40% faster learning compared to traditional methods. The company's proprietary platform features enterprise-grade security, real-time performance tracking, and the ability to deploy across any interactive medium. Their patented HapticVR integration replicates true tissue resistance and surgical tool feedback, enabling surgeons to master complex procedures safely and repeatedly. Fundamental XR serves pharmaceutical companies, medical device manufacturers, hospitals, and training institutions, providing both ready-made and fully customized simulation solutions. The company has been recognized by Frost & Sullivan as Company of the Year in 2023 and 2026 for the global VR surgical simulation and training industry.
Company description Fundamental XR official website
Mission. Immersive technology to accelerate human excellence.
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Company milestones
Frost & Sullivan Company of the Year 2023 in global VR surgical simulation and training industry. Scaled to 200+ healthcare institutions and 50+ countries.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Track usage and measure learning with comprehensive training and assessment monitoring
Complete immersive XR training solution for medical, manufacturing, and growth teams in MedTech
Patented haptic-enabled VR simulation for surgical training with realistic tissue feedback
Blends virtual content with real-world settings for live skills support and procedural guidance
Haptic VR for cataract, retina and gene therapy surgical training
Immersive diagnostic training for neonatal retinopathy assessment
Scale robotic platform training without the OR
Immersive experiences that place users in real world medical environments
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Overall training effectiveness
Compared to traditional training methods
Robotics training efficiency
Platform usage across all clients
Teaching neonatal retinopathy diagnosis to pediatric ophthalmologists
Scale education and cut costs in endovascular training
400% reduction in physical setup assistance
Deliver global scale training for entirely new gene therapy surgical technique
Achieved global scale delivery
Delivering global scale to an entirely new gene therapy surgical technique
Global scale achieved
Establish gold standard for injection training using immersive XR
Became the gold standard for injection training
Bespoke ophthalmic surgical simulations
Bespoke ophthalmic surgical simulations
Expand global access to ophthalmic skills training
Over 30 countries serviced
Expand global access to ophthalmic skills training
293% increase in user confidence
Expanding global access to ophthalmic surgical training
22 institutions in 10 countries with 400+ active users and 1,100+ training hours delivered
Scale robotic training with speed, accuracy, and cost savings
400% reduction in physical setup assistance
Scale robotic training with speed, accuracy, and savings
Global scale achieved
Transform urology training at scale using digital twins and virtual ORs
Transformed urology training at scale with digital twin and high-fidelity OR environments
Digital twin and virtual ORs transformed urology training at scale
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Fundamental XR's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI, virtual reality, augmented reality, or immersive technologies to provide medical education, surgical training, clinical skills development, or continuing medical education for healthcare professionals. Focuses on training and skills development rather than direct patient care delivery.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.